A high CD34+ cell dose is associated with better disease-free survival in patients with low-risk diseases undergoing peripheral blood stem cell transplantation from HLA-matched related donors
2006 ◽
Vol 941
(1)
◽
pp. 147-154
◽
2008 ◽
Vol 14
(2)
◽
pp. 9-10
2009 ◽
1990 ◽
Vol 30
(6)
◽
pp. 511-515
◽
2003 ◽
Vol 18
(11)
◽
pp. 2431-2433
◽
2004 ◽
Vol 20
(10)
◽
pp. 506-511
◽
2000 ◽
Vol 26
(11)
◽
pp. 1247-1249
◽